Live Breaking News & Updates on Kero Quarterly Report|Page 1

Stay updated with breaking news from Kero quarterly report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Corrected: Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension

Corrected: Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Justin Frantz , Jasbirs Seehra , Mardi Gomberg Maitland , Clinical Research , Keros Therapeutics Inc , Drug Administration , Steering Committee Chair , Pulmonary Hypertension Program , Exchange Commission , Keros Therapeutics , Host Conference Call , Pulmonary Arterial , Chief Clinical Research Officer , Medicine Health Sciences , George Washington University , Pulmonary Hypertension , Chief Executive Officer , Private Securities Litigation Reform Act , Kero Quarterly Report ,

Keros Therapeutics : Hematology Franchise Investor Call Presentation

Hematology Franchise:

Program Updates and Summary of Data Presented

at 28th Annual Congress of the European

. | June 9, 2023 ....

Exchange Commission , Securities Litigation Reform Act , Kero Quarterly Report , Keros Therapeutics , Nc Stock Exchange , Press Release , He Kros Us4923271013 ,